A federal court in San Francisco has ruled that Bayer AG's product Roundup was a "substantial factor" in person's non-Hodgkin's lymphoma. That's according to the Wall Street Journal.
The San Francisco jury's preliminary verdict comes after a California state court awarded $289 million in damages to a school groundskeeper in August 2018. The damages were subsequently reduced to $78 million. Bayer took ownership of Roundup when in purchased agrochemical company Monsanto for $62.5 billion. Phase two of the trial will focus on finagling liabilities and damages.